WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence

Eur Respir J. 2020 Mar 5;55(3):1902325. doi: 10.1183/13993003.02325-2019. Print 2020 Mar.

Authors

Dennis Falzon¹, Holger J Schünemann², Matteo Zignol³, Fuad Mirzayev³, Tereza Kasaeva³

Affiliations

¹ Global TB Programme, World Health Organization, Geneva, Switzerland [email protected].
² Dept of Health Research Methods, Evidence and Impact, and Dept of Medicine, McMaster University, Hamilton, ON, Canada.
³ Global TB Programme, World Health Organization, Geneva, Switzerland.

PMID: 32139588
DOI: 10.1183/13993003.02325-2019

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents
Humans
Tuberculosis, Multidrug-Resistant*
World Health Organization

Substances

Antitubercular Agents

Grants and funding

001/WHO_/World Health Organization/International